Reference: 35/2019
Application deadline: 31/01/2020
Number of vacancies: 1
Job description:
The Tumor Biomarkers Group led by Josep Villanueva at the Vall d´Hebron Institute of Oncology´s (VHIO) seeks to appoint a Laboratory Technician. The main goal of our laboratory is to characterize the mechanisms adopted by cancer cells to communicate amongst themselves as well as their microenvironment during tumorigenesis, and exploit these data to advance biomarker and drug target discovery.
We seek an organized, motivated and team-oriented individual with prior experience working in a molecular/cell biology research laboratory. The successful candidate will work on a new project to identify biomarkers and characterize the mechanisms of to novel anti-breast cancer drugs.
Requirements:
- Applicants must have a BSc or FPII, and at least two years’ experience in molecular and cellular biology techniques.
- Experience in tumor cell culture and protein immunoassays by Western Blot and ELISA is required.
- Knowledge in fluorescence microscopy will be favorably considered.
- The successful candidate will also be able to communicate well in English.
Additional information:
Salary will be based on the specific profile and experience of the candidate.
Application:
Applicants must submit a curriculum vitae and letter of intent via email: selecciorrhh@vhio.net, including the reference number 35/2019. Please also attach a letter of reference, if available.
About VHIO:
Under the leadership of Josep Tabernero, the Vall d’Hebron Institute of Oncology (VHIO), has established itself as a comprehensive cancer center of proven excellence internationally. It is also thanks to VHIO’s optimal organizational structure based on a purely multidisciplinary and translational model that VHIO talents continue to anticipate and tackle the many unresolved questions in combatting this multifaceted and heterogeneous disease.
Located within the Vall d’Hebron Barcelona Hospital Campus, our researchers closely collaborate and interact with Vall d’Hebron physician-scientists. Translational science and clinical research are therefore tightly connected which promotes superb interaction and teamwork which, in turn, accelerates the bench-bedside-bed cycle of knowledge.
This privileged environment affords VHIO direct access to patients as well as the entire spectrum of oncology professionals who care for them, and a second-to-none appreciation of how cancer science can translate into more powerful, targeted treatments and better practice for the care of patients.
VHIO’s pioneering model and programs, coupled with its belief in combining strengths through cross-border collaborations, continue to spur advances in reversing cancer resistance, halting metastatic spread, and more effectively treating even the most undruggable tumor types.
VHIO’s translation toward precision oncology: https://www.vhio.net
Vall d’Hebron Institute Oncology (VHIO) endorses the Requirements and Principles of the European Charter for Researchers, the Code of Conduct for the Recruitment of Researchers promoted by the European Commission and follows Equal Opportunities policies.
On 10th April 2018 VHIO was awarded the “HR Excellence in Research” logo. Our Institute was consequently granted permission to use the HR Excellence in Research Award logo as demonstration of its stimulating and favourable work environment in line with the Charter & Code.
